People
Champions Oncology expands bioanalytical services with new technology and leadership
8 December 2025 - Champions Oncology Inc (NASDAQ:CSBR), a technology-enabled oncology research organisation, announced on Monday that it has expanded its clinical bioanalytical services with the integ...
Kedrion's investigational treatment for Congenital Aceruloplasminemia receives European Orphan Drug Designation
28 November 2025 - Kedrion Biopharma, an Italy-based biopharmaceutical company, announced on Thursday that it has received Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) for it...
PhaseV receives three industry honours for AI in clinical development
7 November 2025 - PhaseV, a developer of advanced AI/ML solutions to optimise clinical development, said on Thursday that it has received three 2025 industry honours.The company was named to CB Insigh...
Oxford Nanopore and bioMérieux introduce AmPORE-TB for rapid tuberculosis resistance characterisation
5 November 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) and UK-based molecular sensing technology company Oxford Nanopore Technologies (LON:ONT) on Wednesday announced the ...
Galapagos plans to wind down cell therapy business following strategic review
21 October 2025 - Belgian biotechnology company Galapagos NV (Euronext Brussels:GLPG) (NASDAQ:GLPG) on Tuesday announced its intention to wind down its cell therapy business following a comprehensive ...
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
16 October 2025 - Sebela Women's Health Inc, part of US pharmaceutical company Sebela Pharmaceuticals, announced on Wednesday that its MIUDELLA Hormone-Free Copper Intrauterine System (IUS) has b...